These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8502067)

  • 1. [Suppression of bone marrow after drug interaction].
    Spigset O; Messner T
    Lakartidningen; 1993 Jun; 90(22):2138-40. PubMed ID: 8502067
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute bone marrow suppression with low-dosage methotrexate].
    Brussaard HE; van Eijk CL; van Toorn DW; van Seters WA; de Wit RF
    Ned Tijdschr Geneeskd; 1987 Dec; 131(51):2369-72. PubMed ID: 3696284
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulphamethoxazole induced pancytopenia].
    Shimada T; Nishimura Y; Funada Y; Takenaka K; Kobayashi K; Urata Y; Yosimura S; Nishiuma T; Satouchi M; Yokoyama M
    Arerugi; 2004 Jun; 53(6):575-81. PubMed ID: 15247519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole.
    Thomas DR; Dover JS; Camp RD
    J Am Acad Dermatol; 1987 Dec; 17(6):1055-6. PubMed ID: 3501437
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate therapy for psoriasis.
    JAMA; 1988 Nov; 260(20):3003-5. PubMed ID: 3184363
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose methotrexate toxicity.
    Pivovarov K; Zipursky JS
    CMAJ; 2019 Apr; 191(15):E423. PubMed ID: 30988043
    [No Abstract]   [Full Text] [Related]  

  • 7. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment.
    Maricic M; Davis M; Gall EP
    Arthritis Rheum; 1986 Jan; 29(1):133-5. PubMed ID: 3484954
    [No Abstract]   [Full Text] [Related]  

  • 8. Folate with methotrexate: big benefit, questionable cost.
    Brownell I; Strober BE
    Br J Dermatol; 2007 Jul; 157(1):213. PubMed ID: 17578449
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fatal pancytopenia and methotrexate-trimethoprim-sulfamethoxazole interaction].
    Bartha P; Bron R; Levy Y
    Harefuah; 2004 Jun; 143(6):398-400, 464. PubMed ID: 15524092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
    Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
    Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near fatal drug interactions with methotrexate given for psoriasis.
    Ng HW; Macfarlane AW; Graham RM; Verbov JL
    Br Med J (Clin Res Ed); 1987 Sep; 295(6601):752-3. PubMed ID: 3119023
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe bone marrow suppression in a patient with rheumatoid arthritis on methotrexate.
    Iqbal MP; Ali AA; Alvi AA
    J Pak Med Assoc; 1993 Dec; 43(12):262-3. PubMed ID: 8133640
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancytopenia following low-dose oral methotrexate therapy for psoriasis.
    Shupack JL; Webster GF
    JAMA; 1988 Jun; 259(24):3594-6. PubMed ID: 3373706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate in psoriasis: do we need to give a test dose?
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012 Jan; 103(1):1-4. PubMed ID: 22440152
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis.
    Sun CY; Lin HC; Chen YC; Tsai CR; Wu MS
    Chang Gung Med J; 2006; 29(5):513-7. PubMed ID: 17214397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancytopenia after a single intradermal infiltration of methotrexate.
    Cohen PR; Schulze KE; Nelson BR
    J Drugs Dermatol; 2005; 4(5):648-51. PubMed ID: 16167425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of a macrocytic, hyperchromic anemia following alcohol abuse and simultaneous therapy with triamterene and cotrimoxazole].
    Kahl C; Freund M
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2139-41. PubMed ID: 16172954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serious adverse effects of methotrexate therapy in patients with rheumatic arthritis].
    Purokivi M; Myllykangas-Luosujärvi R; Jantunen E
    Duodecim; 1998; 114(21):2187-90. PubMed ID: 11757107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone marrow megaloblastosis associated with the use of pyrimethamine, triamterene and trimethoprim-sulfamethoxazole].
    Anguita T
    Rev Med Chil; 1982 Jun; 110(6):570-9. PubMed ID: 6984535
    [No Abstract]   [Full Text] [Related]  

  • 20. Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate.
    Das JR; Fryar EB; Epie NN; Southerland WM; Bowen D
    Anticancer Res; 2006; 26(3A):1877-83. PubMed ID: 16827120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.